BioSyent (CVE:RX) Share Price Crosses Above 50-Day Moving Average – Here’s Why

BioSyent Inc. (CVE:RX)’s share price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$11.35 and traded as high as C$11.43. BioSyent shares last traded at C$11.43, with a volume of 100 shares.

BioSyent Trading Down 2.3 %

The firm’s 50-day simple moving average is C$11.36 and its 200 day simple moving average is C$10.80. The stock has a market capitalization of C$129.46 million, a P/E ratio of 18.62 and a beta of 0.93. The company has a quick ratio of 6.91, a current ratio of 6.13 and a debt-to-equity ratio of 3.19.

Insider Buying and Selling

In related news, Senior Officer Robert Joseph March sold 4,775 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of C$11.65, for a total value of C$55,628.75. Also, insider FAX Capital Corp. sold 230,800 shares of the business’s stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of C$11.12, for a total value of C$2,566,496.00. In the last quarter, insiders have sold 349,144 shares of company stock valued at $3,903,370. 33.65% of the stock is owned by corporate insiders.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.